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Colitis results from breakdown of homeostasis
between intestinal microbiota and the mucosal im-
mune system, with both environmental and genetic
influencing factors. Flagellin receptor TLR5-deficient
mice (T5KO) display elevated intestinal proinflamma-
tory gene expression and colitis with incomplete
penetrance, providing a genetically sensitized sys-
tem to study the contribution of microbiota to driving
colitis. Both colitic and noncolitic T5KO exhibited
transiently unstable microbiotas, with lasting differ-
ences in colitic T5KO, while their noncolitic siblings
stabilized their microbiotas to resemble wild-type
mice. Transient high levels of proteobacteria, espe-
cially enterobacteria species including E. coli, ob-
served in close proximity to the gut epithelium were
a striking feature of colitic microbiota. A Crohn’s
disease-associated E. coli strain induced chronic
colitis in T5KO, which persisted well after the exoge-
nously introduced bacterial species had been elimi-
nated. Thus, an innate immune deficiency can result
in unstable gutmicrobiota associatedwith low-grade
inflammation, andharboringproteobacteria candrive
and/or instigate chronic colitis.
INTRODUCTION
Inflammatory bowel disease (IBD) is thought to result from
a breakdown in the relationship between the intestinal mucosalCell Hosimmune system and the large microbial biomass, including
about 100 trillion bacteria, that inhabits this organ (Kaser et al.,
2010; Xavier and Podolsky, 2007). The underlying cause(s) of
the disturbance is not well defined but clearly involves both envi-
ronmental and genetic factors. Prominent among environmental
factors is the gut microbiota, in that IBD has been associated
with broad changes in composition of the microbiota in general
and with select bacterial strains that have been suggested to
be opportunistic pathogens (Dupont and Dupont, 2011). For
example, a number of studies of IBD in humans have described
a functional class of Escherichia coli referred to as adherent-
invasive E. coli (AIEC) (Darfeuille-Michaud, 2002). While E. coli,
in general, is a fairly common component of the human micro-
biota, AIEC were identified as E. coli that had seemingly reached
inappropriate locations either adherent to, within, or beyond the
gut epithelium, whereas the vast majority of gut microbiota are
not in direct contact with cells but, rather, are clearly physically
separated by the mucus layer; i.e., glycocalyx (Derrien et al.,
2010). The AIEC reference strain bacteria LF82 displays relatively
high invasiveness in vitro and has been shown to exacerbate
murine colitis in a manner dependent upon its expression of
flagella (Carvalho et al., 2008). While flagellin is a microbe-asso-
ciated molecular pattern that is present at the bacterial surface
of both pathogenic and nonpathogenic E. coli strains, differential
regulation of flagellin expression has been suggested between
commensal bacteria and Crohn’s disease (CD)-associated
AIEC, and differential regulation under the two-component
EnvZ/OmpR regulatory system (Rolhion et al., 2007).
Several genetic polymorphisms in innate immunity have been
described to increase risk of developing IBD (Hugot et al., 2001;
Ogura et al., 2001; Rioux et al., 2007). These associations
support the possibility that IBD can result from a primary innate
immune deficiency. For example, persons homozygous fort & Microbe 12, 139–152, August 16, 2012 ª2012 Elsevier Inc. 139
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to recognize bacterial-derived glycol-peptides have a 17-fold
increased risk of developing IBD (Cho and Brant, 2011). Mecha-
nistic investigations into how such an innate immune deficiency
might eventuate in chronic intestinal inflammation have been
stymied by the experimental result that mice engineered to
lack Nod2 function do not develop intestinal inflammation (Ko-
bayashi et al., 2005), despite exhibiting altered gut microbiota
composition (Mondot et al., 2011; Rehman et al., 2011). How-
ever, some other mice strains with engineered innate immune
deficiencies are prone to developing gut inflammation and may
ultimately prove to shed light on the pathogenesis of IBD. For
example, mice broadly lacking epithelial innate immune function,
due to deletion of IKK in intestinal epithelial cells, develop
uniform severe colitis (Nenci et al., 2007). Such colitis is not
due to microbial onslaught per se but rather appears to be driven
by a secondary, TNF-a-mediated immune response presumably
driven by altered gut bacteria.
A paradigmatically similar, but more subtle, example of an
innate immune deficiency promoting gut inflammation is mice
engineered to lack the flagellin receptor Toll-like receptor 5
(TLR5). TLR5-deficient mice (T5KO) are prone to developing
elevated proinflammatory gene expression in the intestine (Car-
valho et al., 2012; Vijay-Kumar et al., 2007, 2010). The extent to
which such proinflammatory gene expression results in overt
colitis or ‘‘low-grade’’ inflammation (i.e., the intestine appears
histologically normal but exhibits modest elevation in proinflam-
matory gene expression) that correlates with development of
metabolic syndrome characterized by mild obesity and insulin
resistance appears to be modulated by the microbiota. Specifi-
cally, antibiotics ameliorate robust colitis (Vijay-Kumar et al.,
2007), and both low-grade inflammation and metabolic
syndrome could be transferred to germ-free (GF) mice by trans-
ferring the T5KO microbiota (Vijay-Kumar et al., 2010). The
notion that microbiota composition is a key determinant of colitis
in T5KO mice is further supported by the observation that
embryo transplant of T5KO into mice purchased from Jackson
Labs, so as to ‘‘Jacksonize’’ their microbiota, eliminated devel-
opment of spontaneous overt colitis (Vijay-Kumar et al., 2010).
That analogous observations have been made with murine
models of colitis (e.g., IL-10 KO [Matharu et al., 2009; Sellon
et al., 1998]) provides broad support for the notion that the
composition of the gut microbiota is an important environmental
determinant of colitis, but such approaches of complete micro-
biota exchange or ablation have not been especially informative
in defining which changes are closely correlated with colitis
development, nor do they shed much light on underlying mech-
anism. In the absence of such Jacksonization, continued inter-
breeding/backcrossing of T5KO mice and their WT control
relatives eventuates in spontaneous colitis in 10%–25% of
mice. Such incomplete penetrance poses logistical challenges
in experimental design when using this model. However, it is
a higher penetrance rate than that seen for persons homozygous
for the Nod2 frameshift mutation (in which a 17-fold increase
results in a disease risk of perhaps 5%), and well beyond the
4% IBD concordance seen among dizygotic twins (Cho and
Brant, 2011). Thus, we reasoned that examination of the micro-
biota in colitic T5KO mice, their noncolitic littermates, and
closely related WT mice might shed light upon the mecha-140 Cell Host & Microbe 12, 139–152, August 16, 2012 ª2012 Elsevinisms that dictate the extent to which an innate immune defi-
ciency will eventuate in intestinal inflammation. In the present
study, we observed that such an innate immune deficiency
resulted in inability to stably manage the gut microbiota in
general and select flagellate enterobacteria in particular, which
had the ability to drive colitis in T5KO mice.
RESULTS
TLR5-Deficient Mice Are Prone to Develop Postweaning
Gut Inflammation
To better understand the role of gut microbiota in the develop-
ment in T5KO colitis, we temporally analyzed the composition
of the gut microbiota in colitic T5KO mice, littermate T5KO
mice that did not develop overt colitis, and closely related WT
mice. We prospectively collected fecal samples weekly starting
at weaning from a series of litters of WT (n = 18) and T5KO
mice (n = 110). The WT and T5KO mice studied were offspring
ofmice that were littermates (i.e., born of a heterozygous parent),
thus providing a high likelihood that those differences between
WT and T5KO microbiota would be driven by host genotype.
When examined at 12 weeks of age for evidence of colitis, the
majority of T5KO mice lacked evidence of colitis, while a subset
exhibited both colomegaly and splenomegaly (Figures 1A and
1B), features not present in any of the WT mice and which we
have previously observed reliably correlate with robust histo-
pathologic evidence of colitis in T5KO mice (Vijay-Kumar et al.,
2007). The colitic T5KO mice did not cluster within individual ca-
ges but rather had a seemingly random distribution among the
T5KO mice. We next retrospectively analyzed fecal levels of lip-
ocalin-2 (Lcn-2), which we have recently shown is a sensitive and
broadly dynamic marker of intestinal inflammation able to mark
mice with both low-grade inflammation and robust colitis (our
unpublished data). Relative to WT mice, noncolitic T5KO mice
exhibited moderately elevated levels of fecal Lcn-2 in accord
with our report of low-grade inflammation in these mice (Car-
valho et al., 2011, 2012). Moreover, that fecal Lcn-2 levels
were further elevated about 10-fold in colitic T5KO mice sup-
ported the idea that stratifying based on gross measures reliably
differentiated mice with robust and low-grade inflammation (Fig-
ure 1C). While the difference in fecal Lcn-2 between colitic and
noncolitic T5KO mice was already evident upon weaning, it
decreased in the postweaning period in noncolitic T5KO while
increasing during this period in mice that developed colitis, sug-
gesting that noncolitic mice had better managed a proinflamma-
tory challenge. Retrospective analysis of postweaning growth
curves echoed our previous findings (Vijay-Kumar et al., 2010)
that T5KO mice developing colitis exhibited modest reductions
in weight gain while noncolitic T5KO mice displayed increased
postweaning weight gain relative to WT mice (Figure 1D).
Together, these results demonstrate that T5KO mice exhibit
intestinal inflammation, with most mice maintaining low-grade
inflammation but some mice developing robust colitis in the
postweaning period.
Increased Proteobacteria in Colitic T5KO Mice
Changes in the microbiota associated with colitis were analyzed
in WT, noncolitic T5KO, and colitic T5KOmice by quantitation of
total levels of bacteria, using 16S rRNA gene quantitative PCRer Inc.
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Figure 1. Development of Spontaneous Inflammation and Microbial Dysbiosis in T5KO Mice
Wild-type (n = 18) and T5KO mice (n = 110) were housed for 12 weeks in the animal facility to track spontaneous colitic mice (defined as described in the
Experimental Procedures).
(A) Following euthanasia, spleen was isolated and mass measured.
(B) Colon mass.
(C) Stool was collected weekly after weaning and diluted in 500 ml of PBS. Then supernatant was assayed for lipocalin-2 (Lcn-2) expression by ELISA.
(D) Body mass was monitored weekly from week 4 to week 12.
(E) Colon was washed carefully with PBS to remove any stool, and bacterial DNA was isolated. Total adherent bacteria was measured by quantitative PCR
analysis using universal 16S rRNA primers.
(F) Representative electron microscopy observation of colon (magnification, 1,5003).
(G) Muc 2 mucin immunostaining, green. Nuclei were stained using DAPI, blue (scale bar, 20 mM). The data in (E)–(G) are representative of two independent
experiments.*p < 0.05.
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Figure 2. Endpoint Microbiota Composition
in WT, Noncolitic, and Colitic T5KO Mice
Wild-type, noncolitic, and colitic T5KO mice
(n = 6–8 mice per group) were euthanized at
12 weeks old. Cecal contents were collected, and
microbiota composition was analyzed via 16S
rRNA analysis.
(A) Relative abundance of phyla in cecal bacteria.
Table provides mean for each phyla as the
percentage of total sequences analyzed.
(B) Mouse cecal bacterial communities were
clustered using principal coordinates analysis
(PCoA) of the UniFrac unweighted distance matrix.
PC1, PC2, and PC3 are plotted. The percentage of
the variation explained by the plotted principal
coordinates is indicated in the axis labels. Results
are from an analysis of five to six mice per group.
(C) Jackknifing PCoA plot of cecal and fecal
samples from all time points. Point locations are
the average location of 10 jackknife replicates
using 1,000 random sequences per sample, and
ellipses show the confidence based on these
randomizations. Analysis was done by ANOVA,
and statistical significance (p < 0.01) is denoted by
asterisk (*).
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numbers of intestinal mucosa-associated bacteria in noncolitic
compared to colitic T5KO mice (Figure 1E). In accordance,
examination of the intestinal mucosal surface by electron
microscopy revealed frequent presence of clusters of bacteria
in noncolitic T5KO mice (Figure 1F). Such clusters of bacteria
were rarely found in WT mice, likely reflecting that the fixatives/
solvents utilized in this method disassociated most bacterial-
intestinal interactions. Clusters of bacteria were also rarely
seen in colitic T5KO mice. Rather, colitic T5KO mice displayed
occasional patches of bacteria in proximity to cells appearing
to be phagocytes. To better visualize intestinal bacteria in their
native location relative to the gut epithelium and themucus layer,
we utilized fixatives that preserve the juxtaposition of these
structures. WT mice displayed a well-organized mucus layer
similar to that reported previously (Johansson et al., 2008)
(Figure 1G). The mucus layer in noncolitic T5KO appeared rela-
tively normal, although it was modestly thinner than that of
WT mice. In contrast, the mucus structure of colitic T5KO ap-
peared disorganized and, moreover, lacked a well-defined firm142 Cell Host & Microbe 12, 139–152, August 16, 2012 ª2012 Elsevier Inc.inner layer with bacteria close to or in
contact with the gut epithelium.
The composition of the microbiota was
assessed by pyrosequencing the 16S
rRNA genes of cecal bacteria (12-week-
old mice). When viewed at the phylum
level, such endpoint analysis indicated
that the microbiota of WT mice and non-
colitic T5KO mice were quite similar,
while the most notable feature of colitic
T5KO mice was the increase in proteo-
bacteria species (Figure 2A). Principal
coordinates analysis (PCoA) plots of un-
weighted UniFrac (Lozupone and Knight,2005) demonstrated dramatic differences in the species level
composition of colitic T5KO mice and comparatively modest
differences in noncolitic T5KO relative to WT mice (Figure 2B).
Together, these results suggest that loss of TLR5 resulted in
alterations in the gut microbiota, especially in mice that devel-
oped colitis.
Increased Volatility in TLR5-Deficient Mouse Gut
Microbiota
To better understand the extent to which the changes we
observed in the cecal microbiota might drive and/or be a conse-
quence of colitis, we examined the composition of the gut micro-
biota in the fecal samples that were serially collected from each
mouse 1–9 weeks postweaning. The composition of the 9 week
samples was similar to that of cecal contents collected shortly
thereafter, indicating that analysis of these materials reflects
similar parameters. Collective analysis of all temporal fecal
samples collected showed relatively tight clustering of microbio-
tas from WT mice, while a broader and dramatically different
distribution was seen in colitic T5KO mice (Figure 2C). An
Cell Host & Microbe
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many samples clustering near those of WT mice and others
distributed more broadly. These results suggested that although
WT and noncolitic mice eventuate fairly similar microbiotas, they
might have dissimilar temporal patterns of development. To
further investigate this notion, we next compared relative
composition over time from weaning to 11 weeks of age. Such
analysis, namely plot of PC1 versus time, showed clear clus-
tering at initial time points that remained stable over time among
WTmice, whereas T5KO lacked a clear cluster uponweaning but
began clustering based upon eventual development of colitis at
4–5 weeks postweaning (Figure 3A). In accordance with such
delayed stabilization of their microbiotas, greater variability in
microbiotas was observed among all T5KO mice that did, and
did not, develop colitis. Such microbial volatility was evident
when examining week to week changes in individual mice or
looking at the average weekly changes in UniFrac distances in
our groups of mice (Figure 3B). Increased volatility was also
evident by looking at the phylum level. Specifically, the average
composition was relatively constant over the 8 week period of
study in WT mice but appeared to change considerably in colitic
and noncolitic T5KO mice (Figure 3C). Moreover, plotting
temporal phylum composition in individual mice showed mark-
edly greater week to week changes in T5KO mice (both nonco-
litic and colitic) relative to WT mice (Figure 3D). The greater vari-
ability correlated with greater community dissimilarity, which
increased over time in colitic T5KO, as reflected by the greater
slope in Figure 3E.
When analyzed at the phylum level, much of the increased
microbial volatility appeared to be driven by differences in
proteobacteria, which further analysis showed was mostly due
to enterobacteria. Yet, removal of all of the enterobacteria oper-
ational taxonomic units (OTUs) from the analysis did not sig-
nificantly impact the UniFrac-based volatility analysis (see
Figure S1A online), arguing that enterobacteria are but one family
whose abundance changes in T5KO mice. In accordance with
this notion, use of the ‘‘nearest shrunken centroid’’ method
(PAM package for R) to define patterns that could identify colitic
mice found high predictability based on relative abundance of
seven bacterial families (Figure S1B). Use of these criteria to
identify colitic mice based on fecal microbiota composition
had little predictive power upon weaning (error rate close to
50%) but greatly increased in the following weeks (Figure 3F).
Using this method to predict based on class or order showed
only modest predictive power (Figures S1C and S1D). These
results suggest that broad changes across multiple microbial
families are associated with, and could perhaps be predictive
of, development of colitis.
TLR5-Deficient Mice Exhibit Increased
Mucosal-Associated Enterobacteria
In light of our above results, and reports of others, that elevations
in proteobacteria species correlate with colitis (Lupp et al., 2007;
Nagalingam et al., 2011), we further mined our sequencing data
to examine subgroups of this family. Most notably, we observed
markedly higher levels of enterobacteria throughout the interval
studied but particularly prominent in the first few weeks
postweaning (Figure 4A). The dominant OTU of this group,
comprising up to 6% of fecal bacteria, was a 16S rRNACell Hossequence consistent with E. coli (99% match). Consistent with
the fact that the colitic and noncolitic T5KOmicewere littermates
and close relatives of the WT mice, this OTU was detectable in
most noncolitic mice studied but was present in much lower
abundance. The presence/localization of enterobacteria was
examined by FISH using a specific probe and performed on
intestinal samples fixed in a manner that preserves the mucus
layer. Such analysis confirmed the large increase in abundance
of enterobacteria in colitic mice and, moreover, indicated that
some bacteria had penetrated the mucus layer and were very
close to, or in direct contact with, the gut epithelium (Figure 4B).
Thus, overt colitis in colitic T5KO correlated with the presence of
enterobacteria, whose abundance was greatest in the early
postweaning period.
Increased Susceptibility of TLR5-Deficient Mice
to E. coli LF82 Infection
The association of enterobacteria with colitis could be a conse-
quence of colitis and/or reflect a role for such bacteria in driving
disease. While it might seem reasonable to investigate the latter
possibility by simply exposing WT and noncolitic T5KO mice to
select enterobacteria species, interpreting such experiments is
often not straightforward in that basal differences in gut micro-
biota, and consequently, basal state of immune activation, can
have marked effects on the ability of exogenously administered
bacteria to colonize the gut. As an initial attempt to obviate this
concern, we treated WT and noncolitic T5KO mice with strepto-
mycin (to ‘‘level the field’’) and then challenged them with an
enterobacteria species associated with CD in humans, namely
AIEC reference strain LF82. Levels of AIEC LF82 in feces, known
to reflect colonization levels, were about 10-fold greater in T5KO
mice from days 3–6, suggesting that loss of TLR5 impaired the
host’s ability to manage these flagellate bacteria (Figure S2A).
Such delayed bacterial clearance by T5KO, relative to WT,
mice was not seen upon exposure to a flagellin-deficient AIEC
LF82 mutant, indicating that the increased susceptibility of
T5KO to AIEC LF82 colonization reflects a direct role for TLR5
in recognition of AIEC LF82 flagella. In fact, we observed that
T5KO mice cleared aflagellate AIEC LF82 more efficiently than
WT mice did (Figure S2B), perhaps reflecting that the previously
defined T5KO basal phenotype of nonspecific resistance to
some bacteria (Vijay-Kumar et al., 2008) was not fully corrected
by reducing total bacterial loads with streptomycin treatment. In
any event, the importance of the TLR5-flagellin interaction in host
defense against AIEC LF82 is highlighted by the observation that
loss of flagellin markedly enhances colony-forming unit (CFU)
levels in WT mice but has no effect in T5KO mice. To investigate
the functional consequences of the inability to manage AIEC
LF82, we examined the extent to which these bacteria could
induce gut inflammation in these mice, focusing on ceca where
colonization of AIEC LF82 is highest in mice. Cecal inflammation
is known to correlate with changes in gross morphology, partic-
ularly contraction or shrinkage, of this organ. This phenotype
was readily apparent in T5KO mice colonized with flagellate,
but not in T5KO mice infected with aflagellate AIEC LF82, nor
in WT mice colonized with either bacterial strain (Figure S2C).
In accordance with this observation, use of myeloperoxidase
activity as a marker of inflammation and histopathologic exami-
nation of the ceca confirmed that AIEC LF82, particularly whent & Microbe 12, 139–152, August 16, 2012 ª2012 Elsevier Inc. 143
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Figure 3. Increased Volatility in Microbiota of T5KO Mice
Stool from wild-type, noncolitic, and colitic T5KO mice (n = 5–8 mice per group) was collected weekly for 9 weeks after weaning (from 3 weeks old to 11 weeks
old). Stool microbiota composition was analyzed via 16S rRNA analysis.
(A) Mouse cecal bacterial communities were clustered using principal coordinates analysis (PCoA) of the UniFrac unweighted distance matrix. PC1 is plotted for
each time point (from 3 weeks old to 11 weeks old). The time is expressed on the x axis, and the percentage of the variation explained by the plotted principal
coordinates is indicated in the y axis labels. Results are from an analysis of five to eight mice per group (samples generating fewer than 1,000 sequences were
removed from analysis).
(B) After clustering of mouse cecal bacterial communities using principal coordinates analysis (PCoA) of the UniFrac unweighted distancematrix, a representative
mouse has been used to illustrate the time point evolution of the microbiota (top panel). The average of the UniFrac unweighted distance for each category (WT,
noncolitic, and colitic T5KO) between consecutive time points has been calculated (bottom panel).
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Figure 4. Colitic T5KO Mice Harbored
Abnormal Amount of Enterobacteria
(A) Stool from wild-type, noncolitic, and colitic
T5KOmice (n = 6–8mice per group) were collected
weekly for 9 weeks after weaning (from 3 weeks
old to 11 weeks old). Stool microbiota composition
was analyzed via 16S rRNA analysis to determine
the relative abundance of enterobacteria in stool
fromWT, noncolitic T5KO, and colitic T5KOmouse
group.
(B) Microscopic pictures of colon after FISH using
an Alexa 555-conjugated enterobacteria-specific
probe (red) and nuclei in blue after DAPI staining
(magnification, top, 403; bottom, 1003). Related
materials can be found in Figure S2.
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T5KO Mice Harbor Colitic Microbiotaflagellate, was a significant trigger of gut inflammation in T5KO,
but not WT mice (Figures S2D–S2F).
AIEC LF82 Infection Induces Early Gut Inflammation
in TLR5-Deficient Mice
A major limitation to the use of antibiotics to study the role of the
gut microbiota is that antibiotics alter but do not eliminate this
complex microbial community (Antunes and Finlay, 2011).
Thus, to better investigate the role of TLR5 upon exposure to
AIEC strain LF82, we next utilized the approach of using GF
T5KO and WT mice. In contrast to our colony of noncolitic
T5KO mice, which have elevated proinflammatory/antimicrobial
gene expression and metabolic syndrome, GF T5KO mice were
metabolically indistinguishable from WT GF mice and lacked
elevation in the proinflammatory marker Lcn-2 that sensitively
reflects gut inflammation in T5KO mice (Figures S3A–S3F). The
GF status of T5KO and WT mice was confirmed by verifying
a >6 log reduction in 16S fecal DNA and a reduction by 10-fold
of fecal Lcn-2 expression (Figures S3F and S3G). Subsequently,
GF WT and T5KO mice were colonized (mono-associated) by
oral gavage with 107 AIEC LF82 bacteria and assayed for devel-
opment of colitis 2 weeks later. Mono-association with AIEC
LF82 did not induce inflammation in WT mice but caused
moderate colitis in T5KO mice (as assessed by gross, biochem-(C) Relative abundance of phyla in stool bacteria from WT (left panel), noncolitic T5KO (middle panel), and c
(D) Relative abundance of phyla over time (from 3 weeks old to 11 weeks old) in stool bacteria from individual
colitic T5KO (right panel) mice.
(E) Semivariogram plot of community dissimilarity (UniFrac, y axis) versus days dissimilarity (Euclidean, x ax
(F) Overall misclassification error rates using nine families at eachweek. Analysis was done by ANOVA, and sta
(*). Related materials can be found in Figure S1.
Cell Host & Microbe 12, 139–152ical, histopathological, and inflammatory
marker Lcn-2 measurements [Figures
5A–5G]). Microscopic examination of
localization of E. coli in the mono-
associated mice failed to detect closely
adherent bacteria at the 2 week time
point, suggesting the bacteria may only
colonize rare breaches in the mucosa, in
accordance with earlier studies on the
interaction of this microbes with the
murine intestine (Carvalho et al., 2009).
That AIEC LF82 failed to induce colitis inWT mice and induced only moderate colitis in T5KO mice is in
accord with a recent report that microbial virulence factor ex-
pression requires commensal microbiota (Kamada et al., 2012)
and suggests the importance of examining how mono-associ-
ated mice might fare when not maintained in isolators. Thus,
we next administered AIEC strain LF82 to GF mice that were
subsequently removed from GF isolators and placed in specific
pathogen-free housing. Under these conditions, AIEC LF82
persistence would require outcompeting other microbes that
quickly colonize GF mice placed in SPF housing regardless of
whether they are, or are not, deliberately ‘‘conventionalized’’
(Figure S4A). WT GF mice administered AIEC LF82 did not
exhibit any indication of illness, whereas T5KO mice exhibited
mild weight loss and diarrhea from days 3 to 7 postinfection
(Figure 6A). Such clinical-type symptoms paralleled reduced
clearance of AIEC LF82, which became apparent 5 days
postinfection (Figure 6B). Mice were euthanized 7 days postin-
fection and subsequently examined for various inflammatory
indices and immunological parameters previously used to char-
acterize spontaneous T5KO colitis. T5KO mice exhibited all
examined typical features of spontaneous T5KO colitis, in-
cluding splenomegaly, shortened but thickened colon (i.e., colo-
megaly), elevated levels of colonic MPO, histopathological
scoring, bacterial translocation, and colon Lcn-2 expressionolitic T5KO (right panel) mouse group.
WT (left panel), noncolitic T5KO (middle panel), and
is).
tistical significance (p < 0.01) is denoted by asterisk
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Figure 5. Mono-Association of Crohn’s Disease-Associated Adherent-Invasive E. coli Strain LF82 Infection Increased Intestinal Inflamma-
tion in T5KO Mice
(A) Following euthanasia, spleen was isolated and mass measured.
(B) Colon mass.
(C) Ratio between colon weight and colon length.
(D) Colon MPO activity.
(E and F) Histological score and representative H&E stained colon (magnification, 1003).
(G) Colon was cultured for 24 hr, at which time supernatant was assayed for Lcn-2 by ELISA. *p < 0.05. Related materials can be found in Figure S3.
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in GF T5KOmice colonized with the commensal flagellate E. coli
strain F-18, which is commonly used as a commensal E. coli
isolate (Figures S4B–S4J). Colon cytokine levels of AIEC LF82-
colonized mice also reflected what we previously observed in
T5KO mice with low-grade inflammation (Vijay-Kumar et al.,
2007), namely reduced levels of the cytokines CXCL1 and IL-6,
which are secreted by epithelial cells in response to flagellin
and elevated levels of ‘‘master proinflammatory cytokines’’
IL-1b and TNF-a, which are predominantly secreted by immune
cells (Figures 6L–6O). A similar pattern of cytokine levels was
seen in sera (Figure S5). Together, these results suggest that
colitis in T5KO mice can be triggered by selected E. coli patho-
bionts such as AIEC that might also be present, but not promote
colitis, in WT mice.146 Cell Host & Microbe 12, 139–152, August 16, 2012 ª2012 ElseviDelayed Clearance of AIEC LF82 Promotes Chronic
Intestinal Inflammation
While use of antibiotics or GF mice can overcome the inability
of some bacteria to colonize the mouse intestine, stopping use
of the antibiotics or permitting acquisition of a microbiota by
removal from GF housing often results in quick depletion of
such administered bacteria. Thus, any bacterium able to play
a significant role in the spontaneous chronic colitis exhibited
by some T5KO mice would require an ability to persist beyond
acquisition of a microbiota and/or trigger events that would
result in chronic inflammation after the bacteria had been cleared
from the GI tract. To investigate the extent to which AIEC might
display such characteristics in T5KO mice, we colonized GF WT
and T5KO mice with AIEC, or as controls treated with sterile
PBS, placed them in SPF housing, and monitored them forer Inc.
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Figure 6. Germ-free T5KO Mice Are Highly Susceptible to Early AIEC LF82 Infection
Germ-free wild-type and T5KO mice (n = 4 mice per group) were orally infected with 107 flagellate AIEC LF82 bacteria.
(A) Body mass was monitored daily during the treatment.
(B) Numeration of AIEC LF82 present in the WT or T5KO mouse stool from day 1 to day 7 postinfection.
(C) Following euthanasia, spleen was isolated and mass measured.
(D) Colon mass.
(E) Ratio between colon weight and colon length.
(F) Gross picture of colon.
(G) Colon MPO activity.
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T5KO Mice Harbor Colitic Microbiota119 days. Analogous to our shorter term experiment, T5KOmice
lacked the rapid reduction in AIEC LF82 levels exhibited by WT
mice, although, like WT mice, AIEC levels were very low by
5 weeks postinoculation and did not differ significantly from
WT mice from that time through the end of the experiment
(Figure 7A). Such delayed clearance correlated with transient
diarrhea 5–15 days postinoculation that was accompanied with
transient weight loss during this time. Despite the lack of differ-
ence in AIEC LF82 levels beyond 42 days postinoculation, the
reduced weight gain of T5KO mice relative to WT persisted
over the following 90 days (Figure 7B). Analogously, higher levels
of the fecal inflammatory marker Lcn-2 persisted throughout the
119 day experiment, despite the levels of AIEC LF82 being
similar in WT and T5KO mice by 42 days (Figure 7C). Examina-
tion of themurine intestine at the 120 day time point by the afore-
mentioned parameters revealed that T5KO mice that were
exposed to AIEC LF82 exhibited typical features of chronic
colitis including splenomegaly, colomegaly, histopathological
scoring, and elevated inflammatory markers such as MPO and
Lcn-2 (Figures 7D–7N). In accordance with our previous work,
chronic colitis in T5KO mice associated with elevated levels of
CXCL1 and IL-6 (Vijay-Kumar et al., 2007). Importantly, neither
relatively delayed bacterial clearance nor chronic intestinal
inflammation was observed in GF T5KO mice colonized with
aflagellate AIEC LF82, indicating a direct role for TLR5 in recog-
nizing AIEC flagellin to protect against this pathobiont. Together,
these results indicate that loss of TLR5 renders mice susceptible
to colonization by select flagellate bacteria that can drive gut
inflammation capable of persisting even when the bacteria is
present at only very low levels and support the general notion
that chronic intestinal inflammation can result from an innate
immune deficiency and be triggered by transient colonization
by select bacteria.
DISCUSSION
Alterations in the gut microbiota have long been suspected to
play an important role in the pathogenesis of IBD. Consequently,
there has been considerable interest in applying recent ad-
vances in DNA sequencing technology to interrogate the gut
microbiota in this disorder (Walker et al., 2011a, 2011b; Willing
et al., 2010). While interperson variance, combined with the rapid
and dramatic effects of diet, poses a considerable obstacle to
this endeavor, perhaps the greatest obscurant to understanding
the role of themicrobiota in IBD, and other diseases, is that it has
generally only been possible to examine the microbiota in
patients after they have been diagnosed, which typically takes
place well after initial symptoms occurred. Thus, while a number
of studies have reported alterations in the microbiota in IBD, the
extent to which these occur late or early in the disease process,
and whether they are a cause or consequence of disease,
remains undefined. Herein, to address these challenges and
better understand the role of the microbiota in colitis, we tempo-(H and I) Histological score and representative H&E-stained colon (magnification
(J) Bacterial translocation by numbering AIEC LF82 CFU present in the spleen at
(K–O) Colon was cultured for 24 hr, at which time supernatant was assayed for Lcn
(N), and TNF-a (O), by ELISA. *p < 0.05. Related materials can be found in Figure
148 Cell Host & Microbe 12, 139–152, August 16, 2012 ª2012 Elsevirally examined, from weaning to colitis establishment, the micro-
biota in T5KO mice, which are prone to developing intestinal
inflammation.
Consistent with the notion that gut microbiota is acquired from
one’s early environment, overall microbiota composition was
similar in the early postweaning period in T5KO mice that devel-
oped colitis and their littermates that did not. Nor was there
a stark difference between microbiota of T5KO and closely
related WT mice upon this initial sampling. Rather, the most
striking overall difference that we observed was the greater vola-
tility (week to changes) that occurred in T5KO mice that did, or
did not, develop colitis. We hypothesize that such volatility
reflects that, consistent with its preferential expression on
mucosal tissues, TLR5 is a ‘‘first responder’’ to occasional
breaches that sporadically occur throughout the mucosa—
a vision promoted by the notion of 100 trillion bacteria populating
a surface the size of a tennis court. Accordingly, we interpret that
such volatility is accompanied by elevated expression of Lcn-2,
and likely numerous elevations in antibacterial/proinflammatory
gene expression (Carvalho et al., 2012; Vijay-Kumar et al.,
2007), which reflects the complex redundant ability of the
immune system to secondarily manage such disturbances.
From an evolutionary perspective, we propose that such mach-
inations of the TLR5-deficient immune system are highly effec-
tive in that most mice did not develop overt colitis but rather
have increases in weight/adipose tissue that often correlate
with increased breeding in mice (Vijay-Kumar et al., 2010).
Accordingly, noncolitic T5KO mice breed at least as well as
WT mice, whereas, like other colitic mice, colitic T5KO produce
very few offspring.
The other major pattern evident in these results was the
increase in proteobacteria, specifically enterobacteria in colitic
T5KO. While it is known that increases in proteobacteria can
be a consequence of inflammation (Lupp et al., 2007; Nagalin-
gam et al., 2011), the levels of proteobacteria/enterobacteria
were greatest 3 weeks postweaning and were seemingly
controlled well in advance of when the mice were euthanized
and colitis realized, which suggests a potentially causative
role. To investigate this notion, we colonized WT and T5KO
with an enterobacteria species known to associate with CD,
namely AIEC reference strain LF82 (Darfeuille-Michaud et al.,
1998). While neither WT nor T5KO mice are normally colonizable
by this bacterium (Carvalho et al., 2009), the restriction could
be overcome by use of antibiotics and/or use of GF mice. While
both approaches afforded detectable colonization, the latter
approach resulted in amore lasting, albeit still transient coloniza-
tion by this bacterium, in accord with our result that the bacte-
rium does not tightly adhere to the mucosa. In either case, clear-
ance of flagellate AIEC strain LF82, but not an aflagellate
isogenic mutant strain, was delayed in T5KO mice, indicating
a role for TLR5 in protecting against this, and perhaps other
motile, bacteria. Failure to efficiently clear AIEC strain LF82
correlated with development of colitis. Such colitis was evident, 1003).
day 7 postinfection.
-2 (K) and several proinflammatory cytokines, namely CXCL1 (L), IL-6 (M), IL-1b
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119 days, even though levels of the bacteria were similar
between WT and T5KO mice by 42 days. We envisage that
such persistent inflammation could reflect a need for chronic
elevation of the pathways that contain the bacteria in the
absence of TLR5 or that priming of the adaptive immune system
that has taken place while the immune system-microbiota rela-
tionship was developing resulted in a chronic inflammatory state.
Together, these results suggest that the elevated enterobacteria
observed in colitic T5KO mice are likely both a cause and
a consequence of colitis and, moreover, that classic concepts
of microbial causation of disease such as Koch’s postulates
may not be sufficient to describe the role of the microbiota in
disease.
The observation that several polymorphisms in genes with
innate immune function confer risk for IBD makes it tempting
to speculate that the mechanistic paradigms underlying T5KO
colitis may be similar to those underlying IBD. Accordingly, our
results suggest that IBDmight clinically manifest following a pro-
longed, ultimately unsuccessful, attempt by the mucosal
immune system to maintain/contain a stable microbiota while
avoiding the excessive immune responses that can be detri-
mental to the host. In this scenario, a more successful, albeit still
suboptimal, consequence of altered intestinal/microbiota rela-
tionship would be the maintenance of ‘‘low-grade’’ inflammation
that correlates with diseases such as obesity, type 2 diabetes,
and cancer, whose effects generally do not manifest during
one’s prime reproductive years.
Another possibility suggested by our results is that some
IBD-associated bacteria such as AIEC strain LF82 may not
merely colonize the gut as a consequence of disease and/or be
an aggravating factor of established disease but rather might
play an early role in disease pathogenesis, particularly as instiga-
tors of inflammation. We anticipate that ongoing development of
fecal sample banks that catalog specimens throughout life on
persons who develop IBD and control subjects will make it
possible to better address if such instigator bacteria exist in
humans who eventually develop chronic gut inflammation. We
would predict that elevated levels of select bacteria might be
predictors and causative factors of IBD and perhaps other
chronic inflammatory disorders. Should either general develop-
mental microbiota volatility or select bacterial taxa correlate
with future disease development, it would suggest that the possi-
bility of therapeutic manipulations of the microbiota, particularlyFigure 7. Transient AIEC LF82 Infection Resulted in a Chronic Basal In
Germ-free wild-type and T5KOmice (n = 3–7 mice per group) were orally infected
T5KO mice were transferred to a sterile cage without treatment.
(A) Numeration of AIEC LF82 present in the WT or T5KO mouse stool.
(B) Body mass was monitored daily from day 0 to day 35 postinfection and then
(C) Stool was collected daily (D0–D35) or weekly (D42–D119) after AIEC LF82 inf
expression by ELISA.
(D) Following euthanasia, spleen was isolated and mass measured.
(E) Colon mass.
(F) Ratio between colon weight and colon length.
(G) Colon MPO activity.
(H) Fecal Lcn-2 was assayed by ELISA at the end of the experiment.
(I and J) Histological score and representative H&E-stained colon (magnification
(K–N) Colonwas cultured for 24 hr, at which time supernatant was assayed for seve
(N) by ELISA. *p < 0.05. Related materials can be found in Figure S5.
150 Cell Host & Microbe 12, 139–152, August 16, 2012 ª2012 Elseviearly in life, might be a reasonable means of preventing diseases
associated with active and low-grade intestinal inflammation.
EXPERIMENTAL PROCEDURES
Mice Maintenance
WT and T5KO mice (backcrossed to C57BL/6 mice for ten generations) were
bred and maintained as previously described. All experiments were approved
by appropriate institutional animal use committees. Experimental mice were
weaned at 21 days and maintained for 10 weeks thereafter. Body mass was
measured and stools collected weekly. Mice were stratified as colitic exhibit-
ing splenomegaly (>0.5 g/100 g of body weight) and colomegaly (>1.5 g/100 g
of body weight).
Mucosal Analysis
Electron microscopy (Gilmor et al., 1996), mucous staining (Johansson et al.,
2008), and localization of bacteria therein by fluorescent in situ hybridization
were performed as previously described using probes described in the
Supplemental Information. Myeloperoxidase activity (Castaneda et al.,
2005), histologic scoring of inflammation (Onyeagocha et al., 2009), and assay
of intestinal cytokines (Vijay-Kumar et al., 2007) were measured as previously
described.
Microbiota Analysis
Bacterial 16 s DNA on fecal and cecal samples was performed using theQuan-
titative Insights into Microbial Ecology pipeline as detailed in the Supplemental
Information.
Bacterial Infections
CD-associated AIEC strain LF82 (Darfeuille-Michaud, 2002), isogenic nonfla-
gellate mutant LF82-DfliC (Barnich et al., 2003), S. typhimurium SL3201, and
E. coli F18 were grown overnight at 37C without agitation in Luria-Bertani
(LB) medium. After centrifugation, bacteria were resuspended in PBS and
used to inoculate mice. Acute (Barthel et al., 2003) or chronic colitis was
assessed as described in the Results and figure legends.
Statistical Analysis
Significance was determined using the Mann Whitney t test or one-way
ANOVA (GraphPad Prism software). Differences *p < 0.05 were noted as
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and Supplemental References and can be found with this article
online at http://dx.doi.org/10.1016/j.chom.2012.07.004.
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